Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France.
Department of Neurosurgical Anesthesiology and Critical Care, Pitié-Salpêtrière Hospital, Paris, France.
Clin Neuroradiol. 2024 Dec;34(4):951-957. doi: 10.1007/s00062-024-01438-8. Epub 2024 Aug 12.
So-called contrast-induced encephalopathy (CIE) is a rare but worrying condition occurring after cerebral angiography or neuroendovascular interventions using iodine contrast media. This study aimed to compare cerebral iodine concentrations in patients suspected of having CIE after endovascular procedures to those in matched controls.
This is a retrospective monocentric study of 25 suspected CIE patients in a tertiary care teaching hospital diagnosed from June 2017 to February 2024. Cerebral multispectral computed tomography (CT) iodine mean concentrations were measured and compared with 1:1 matched controls using the CT constructor's workstation in the whole brain and in specific regions of interest (ROIs) corresponding to a vascular territory downstream of the procedure. Concentration values were compared with paired samples t‑test.
During the study period, 1097 patients underwent aneurysm embolization and 137 arteriovenous malformation (AVM) embolization procedures. So-called CIE was suspected in 25 patients after aneurysm or AVM embolization (2%). Mean iodine concentrations in the procedure vascular territory ROIs were higher in suspected CIE cases (mean 543 ± 147 µg/cm) compared to matched controls (mean 463 ± 141 µg/cm; p = 0.01). Whole brain mean iodine concentrations were modestly higher in CIE patients compared to controls across all subgroups, without reaching statistical significance.
CIE may be associated with modest increase in CT iodine concentration in the procedure vascular territory after neurointerventional procedures. The underlying pathophysiology of this condition remains uncertain and merits further investigation.
Contrast-induced encephalopathy (CIE) is known as a rare neurologic condition following iodine contrast media use in neuroendovascular interventions, with unclear pathophysiology.
This study provides evidence that suspected CIE is associated with higher cerebral iodine concentrations in affected vascular territories, a novel quantifiable change. Implications for research, practice, or policy: These findings suggest the potential for iodine concentration monitoring to refine CIE diagnosis and prevention strategies in clinical practice.
所谓的对比剂诱发脑病(CIE)是一种罕见但令人担忧的情况,发生在脑血管造影或神经血管介入使用碘造影剂后。本研究旨在比较血管内手术后疑似 CIE 患者的脑碘浓度与匹配对照组。
这是一项回顾性单中心研究,纳入了 2017 年 6 月至 2024 年 2 月在一家三级教学医院诊断为疑似 CIE 的 25 例患者。使用 CT 构建器工作站测量脑多谱 CT(CT)碘平均浓度,并与 1:1 匹配对照组进行比较,全脑和与手术下游血管区域相对应的特定感兴趣区域(ROI)。采用配对样本 t 检验比较浓度值。
在研究期间,1097 例患者接受了动脉瘤栓塞术,137 例患者接受了动静脉畸形(AVM)栓塞术。在动脉瘤或 AVM 栓塞术后,25 例患者(2%)疑似发生 CIE。疑似 CIE 患者的手术血管区域 ROI 碘浓度(平均 543±147μg/cm)高于匹配对照组(平均 463±141μg/cm;p=0.01)。所有亚组中,CIE 患者的全脑平均碘浓度均高于对照组,但无统计学意义。
CIE 可能与神经介入手术后程序血管区域的 CT 碘浓度适度增加有关。这种情况的潜在病理生理学仍不确定,值得进一步研究。
对比剂诱发脑病(CIE)是一种已知的神经疾病,发生在神经血管介入使用碘造影剂后,其病理生理学尚不清楚。
本研究提供了证据表明,疑似 CIE 与受影响血管区域的脑碘浓度升高有关,这是一种新的可量化变化。对研究、实践或政策的影响:这些发现表明,监测碘浓度可能有助于完善临床实践中的 CIE 诊断和预防策略。